A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia

NCT03563560 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Alvocidib
DRUG: Cytarabine
DRUG: Mitoxantrone
DRUG: Cytarabine
DRUG: Daunorubicine

Sponsor

Sumitomo Pharma Co., Ltd.